FI944546L - Enantiomeerinen 1-fenyyli-2-(2pyridinyyli)etyyliamiini neurodegeneratiivisten häiriöiden hoitoon - Google Patents
Enantiomeerinen 1-fenyyli-2-(2pyridinyyli)etyyliamiini neurodegeneratiivisten häiriöiden hoitoon Download PDFInfo
- Publication number
- FI944546L FI944546L FI944546A FI944546A FI944546L FI 944546 L FI944546 L FI 944546L FI 944546 A FI944546 A FI 944546A FI 944546 A FI944546 A FI 944546A FI 944546 L FI944546 L FI 944546L
- Authority
- FI
- Finland
- Prior art keywords
- enantiomeric
- ethylamine
- pyridinyl
- phenyl
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9207339 | 1992-04-03 | ||
GB929207339A GB9207339D0 (en) | 1992-04-03 | 1992-04-03 | Pharmaceutical compound |
GB9208290 | 1992-04-15 | ||
GB929208290A GB9208290D0 (en) | 1992-04-15 | 1992-04-15 | Pharmaceutical compound having neuroprotective properties |
GB9300689 | 1993-04-01 | ||
PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
Publications (3)
Publication Number | Publication Date |
---|---|
FI944546A0 FI944546A0 (fi) | 1994-09-30 |
FI944546L true FI944546L (fi) | 1994-09-30 |
FI105025B FI105025B (fi) | 2000-05-31 |
Family
ID=26300643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944546A FI105025B (fi) | 1992-04-03 | 1994-09-30 | Menetelmä valmistaa (S)-alfa-fenyyli-2-pyridiinietaaniamiinia |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0633879B1 (fi) |
JP (2) | JP3120810B2 (fi) |
KR (1) | KR100259567B1 (fi) |
CN (1) | CN1044367C (fi) |
AT (1) | ATE163925T1 (fi) |
AU (2) | AU3897693A (fi) |
CA (1) | CA2133427C (fi) |
CZ (1) | CZ288519B6 (fi) |
DE (1) | DE69317411T2 (fi) |
DK (1) | DK0633879T3 (fi) |
DZ (1) | DZ1677A1 (fi) |
ES (1) | ES2115055T3 (fi) |
FI (1) | FI105025B (fi) |
HK (1) | HK1009331A1 (fi) |
HU (1) | HU211529A9 (fi) |
IL (1) | IL105276A (fi) |
MA (1) | MA22866A1 (fi) |
MX (1) | MX9301935A (fi) |
MY (1) | MY110149A (fi) |
NO (1) | NO302170B1 (fi) |
NZ (1) | NZ251384A (fi) |
PL (1) | PL180014B1 (fi) |
RU (1) | RU2128650C1 (fi) |
SG (1) | SG47948A1 (fi) |
SK (1) | SK281258B6 (fi) |
TW (1) | TW282455B (fi) |
UA (1) | UA29437C2 (fi) |
WO (1) | WO1993020052A1 (fi) |
ZA (1) | ZA932415B (fi) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9320273D0 (en) * | 1993-04-01 | 1993-11-17 | Fisons Corp | Compound useful in therapy |
EP0648489A1 (en) * | 1988-08-12 | 1995-04-19 | Fisons Corporation | Arylalkylamides having neuroprotective properties |
ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
SE9901077D0 (sv) * | 1999-03-23 | 1999-03-23 | Astra Ab | Novel use |
SE9901237D0 (sv) * | 1999-04-06 | 1999-04-06 | Astra Ab | Novel use |
SE9901340D0 (sv) | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
WO2007017652A2 (en) * | 2005-08-10 | 2007-02-15 | Astrazeneca Ab | Arylakylamines for the treatment of cancer |
EP2610246A1 (en) * | 2008-12-24 | 2013-07-03 | AstraZeneca AB | Ethanamine compounds and methods of using the same |
EP2791352A1 (en) | 2011-12-14 | 2014-10-22 | Astrazeneca AB | Gabr-a2 diagnostic |
HUE045001T2 (hu) * | 2013-11-05 | 2019-12-30 | Astrazeneca Ab | NMDA antagonista prodrugok |
PH12022553502A1 (en) * | 2020-06-23 | 2024-04-22 | Biohaven Therapeutics Ltd | Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0648489A1 (en) * | 1988-08-12 | 1995-04-19 | Fisons Corporation | Arylalkylamides having neuroprotective properties |
-
1993
- 1993-04-01 CZ CZ19942409A patent/CZ288519B6/cs not_active IP Right Cessation
- 1993-04-01 AT AT93907975T patent/ATE163925T1/de active
- 1993-04-01 SG SG1996005610A patent/SG47948A1/en unknown
- 1993-04-01 DK DK93907975T patent/DK0633879T3/da active
- 1993-04-01 PL PL93305404A patent/PL180014B1/pl unknown
- 1993-04-01 AU AU38976/93A patent/AU3897693A/en not_active Abandoned
- 1993-04-01 SK SK1177-94A patent/SK281258B6/sk not_active IP Right Cessation
- 1993-04-01 DE DE69317411T patent/DE69317411T2/de not_active Expired - Lifetime
- 1993-04-01 WO PCT/GB1993/000689 patent/WO1993020052A1/en active IP Right Grant
- 1993-04-01 ES ES93907975T patent/ES2115055T3/es not_active Expired - Lifetime
- 1993-04-01 KR KR1019940703465A patent/KR100259567B1/ko not_active Expired - Lifetime
- 1993-04-01 JP JP05517251A patent/JP3120810B2/ja not_active Expired - Lifetime
- 1993-04-01 CA CA002133427A patent/CA2133427C/en not_active Expired - Lifetime
- 1993-04-01 EP EP93907975A patent/EP0633879B1/en not_active Expired - Lifetime
- 1993-04-01 NZ NZ251384A patent/NZ251384A/en not_active IP Right Cessation
- 1993-04-01 UA UA94095853A patent/UA29437C2/uk unknown
- 1993-04-01 RU RU94042465A patent/RU2128650C1/ru active
- 1993-04-02 IL IL105276A patent/IL105276A/xx not_active IP Right Cessation
- 1993-04-02 ZA ZA932415A patent/ZA932415B/xx unknown
- 1993-04-02 MY MYPI93000602A patent/MY110149A/en unknown
- 1993-04-02 MA MA23157A patent/MA22866A1/fr unknown
- 1993-04-02 MX MX9301935A patent/MX9301935A/es unknown
- 1993-04-03 DZ DZ930038A patent/DZ1677A1/fr active
- 1993-04-03 CN CN93104534A patent/CN1044367C/zh not_active Expired - Lifetime
- 1993-04-30 TW TW082103364A patent/TW282455B/zh not_active IP Right Cessation
-
1994
- 1994-09-30 FI FI944546A patent/FI105025B/fi not_active IP Right Cessation
- 1994-09-30 NO NO943645A patent/NO302170B1/no not_active IP Right Cessation
-
1995
- 1995-06-13 HU HU95P/P00192P patent/HU211529A9/hu unknown
-
1996
- 1996-12-18 AU AU75456/96A patent/AU705419B2/en not_active Expired
-
1998
- 1998-08-21 HK HK98110056A patent/HK1009331A1/xx not_active IP Right Cessation
-
2000
- 2000-05-30 JP JP2000159319A patent/JP2000319259A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5281607B1 (en) | Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases | |
FI933505L (fi) | Foerfarande foer framstaellning av etenpolymerer med en reducerad halt avkomponenter som kan extraheras med hexan | |
NO965377L (no) | Indolinonforbindelser for behandling av sykdommer | |
NO963785D0 (no) | Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser | |
EP0673384A4 (en) | POLYPEPTIDES USEFUL IN TREATING INFLAMMABLE DISEASES. | |
AU6222096A (en) | Phenoxy piperazine derivatives for treating disorders of the dopamine system | |
FI944546L (fi) | Enantiomeerinen 1-fenyyli-2-(2pyridinyyli)etyyliamiini neurodegeneratiivisten häiriöiden hoitoon | |
FI103033B1 (fi) | Menetelmä titaanin talteenottamiseksi | |
IT9021645A0 (it) | Procedimento per il trattamento di torbide di raffineria | |
NO974569L (no) | Benzamider for behandling av neurodegenerative forstyrrelser | |
EE9700268A (et) | Meetod ratseemilise ja enantiomeerse 1-(püridüül)-2-tsükloheksüületüülamiini valmistamiseks | |
NO973366D0 (no) | Fremgangsmåte for behandling av multippel sklerose | |
DK632388D0 (da) | Pharmaceutisk middel til behandling af hypolipidaemi hos pattedyr | |
DE68909304D1 (de) | Aminosäuren für der Behandung neurodegenerativer Störungen. | |
NO943723D0 (no) | Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes | |
FI943833A0 (fi) | Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi | |
FI952953A0 (fi) | Aineita metabolisten luustosairauksien hoitamiseen | |
ITPD910141A1 (it) | Procedimento perfezionato per la realizzazione di calzature | |
FR2688505B1 (fr) | Nouveau procede de preparation de 4-pyrimidinones. | |
FI943660A0 (fi) | Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi | |
KR970020846U (ko) | 근골격계질환 치료보조용 반창고 | |
FI941667A (fi) | Menetelmä terapeuttisesti käyttökelpoisten trisubstituoitujen sykloalkaanijohdannaisten valmistamiseksi | |
KR960010871U (ko) | 스티어링 휘일의 높이를 조절하기 위한 장치 | |
KR950700748A (ko) | 섬유증 질환의 치료방법(use of mannose phosphates for the treatment of fibrotic disorders) | |
ITMI921770A1 (it) | Composizioni farmaceutiche atte al trattamento dei disturbi della memoria. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: ASTRA AB |
|
MA | Patent expired |